242 related articles for article (PubMed ID: 17252190)
1. Intestinal absorption of miltefosine: contribution of passive paracellular transport.
Ménez C; Buyse M; Dugave C; Farinotti R; Barratt G
Pharm Res; 2007 Mar; 24(3):546-54. PubMed ID: 17252190
[TBL] [Abstract][Full Text] [Related]
2. Modulation of intestinal barrier properties by miltefosine.
Menez C; Buyse M; Chacun H; Farinotti R; Barratt G
Biochem Pharmacol; 2006 Feb; 71(4):486-96. PubMed ID: 16337152
[TBL] [Abstract][Full Text] [Related]
3. Inward translocation of the phospholipid analogue miltefosine across Caco-2 cell membranes exhibits characteristics of a carrier-mediated process.
Ménez C; Buyse M; Farinotti R; Barratt G
Lipids; 2007 Apr; 42(3):229-40. PubMed ID: 17393228
[TBL] [Abstract][Full Text] [Related]
4. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
[TBL] [Abstract][Full Text] [Related]
5. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers.
Liu DZ; LeCluyse EL; Thakker DR
J Pharm Sci; 1999 Nov; 88(11):1161-8. PubMed ID: 10564065
[TBL] [Abstract][Full Text] [Related]
6. Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro.
Ménez C; Buyse M; Besnard M; Farinotti R; Loiseau PM; Barratt G
Antimicrob Agents Chemother; 2006 Nov; 50(11):3793-800. PubMed ID: 16966395
[TBL] [Abstract][Full Text] [Related]
7. Intestinal absorptive transport of the hydrophilic cation ranitidine: a kinetic modeling approach to elucidate the role of uptake and efflux transporters and paracellular vs. transcellular transport in Caco-2 cells.
Bourdet DL; Pollack GM; Thakker DR
Pharm Res; 2006 Jun; 23(6):1178-87. PubMed ID: 16741656
[TBL] [Abstract][Full Text] [Related]
8. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
9. The Permeation of Acamprosate Is Predominantly Caused by Paracellular Diffusion across Caco-2 Cell Monolayers: A Paracellular Modeling Approach.
Antonescu IE; Rasmussen KF; Neuhoff S; Fretté X; Karlgren M; Bergström CAS; Nielsen CU; Steffansen B
Mol Pharm; 2019 Nov; 16(11):4636-4650. PubMed ID: 31560549
[TBL] [Abstract][Full Text] [Related]
10. Paracellular calcium transport across Caco-2 and HT29 cell monolayers.
Blais A; Aymard P; Lacour B
Pflugers Arch; 1997 Jul; 434(3):300-5. PubMed ID: 9178630
[TBL] [Abstract][Full Text] [Related]
11. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line.
Grès MC; Julian B; Bourrié M; Meunier V; Roques C; Berger M; Boulenc X; Berger Y; Fabre G
Pharm Res; 1998 May; 15(5):726-33. PubMed ID: 9619781
[TBL] [Abstract][Full Text] [Related]
12. Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size.
Knipp GT; Ho NF; Barsuhn CL; Borchardt RT
J Pharm Sci; 1997 Oct; 86(10):1105-10. PubMed ID: 9344165
[TBL] [Abstract][Full Text] [Related]
13. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Luessen HL; de Leeuw BJ; de Boer BG; Verhoef JC; Junginger HE
Pharm Res; 1997 Sep; 14(9):1197-202. PubMed ID: 9327448
[TBL] [Abstract][Full Text] [Related]
14. Change in tolbutamide permeability in rat jejunum and Caco-2 cells by Sho-saiko-to (Xiao Chai Hu Tang), a Chinese traditional medicine.
Nishimura N; Uemura T; Iwamoto K; Naora K
J Pharm Pharmacol; 2010 May; 62(5):651-7. PubMed ID: 20609069
[TBL] [Abstract][Full Text] [Related]
15. Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.
Yu L; Zeng S
J Pharm Pharmacol; 2007 May; 59(5):655-60. PubMed ID: 17524230
[TBL] [Abstract][Full Text] [Related]
16. Paracellular drug transport across intestinal epithelia: influence of charge and induced water flux.
Karlsson J; Ungell A; Gråsjö J; Artursson P
Eur J Pharm Sci; 1999 Oct; 9(1):47-56. PubMed ID: 10493996
[TBL] [Abstract][Full Text] [Related]
17. Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.
Collett A; Sims E; Walker D; He YL; Ayrton J; Rowland M; Warhurst G
Pharm Res; 1996 Feb; 13(2):216-21. PubMed ID: 8932439
[TBL] [Abstract][Full Text] [Related]
18. Passive transepithelial absorption of thyrotropin-releasing hormone (TRH) via a paracellular route in cultured intestinal and renal epithelial cell lines.
Thwaites DT; Hirst BH; Simmons NL
Pharm Res; 1993 May; 10(5):674-81. PubMed ID: 8321830
[TBL] [Abstract][Full Text] [Related]
19. Effects of cadmium chloride on the paracellular barrier function of intestinal epithelial cell lines.
Duizer E; Gilde AJ; Versantvoort CH; Groten JP
Toxicol Appl Pharmacol; 1999 Mar; 155(2):117-26. PubMed ID: 10053166
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships for enhancement of paracellular permeability by 2-alkoxy-3-alkylamidopropylphosphocholines across Caco-2 cell monolayers.
Liu DZ; Morris-Natschke SL; Kucera LS; Ishaq KS; Thakker DR
J Pharm Sci; 1999 Nov; 88(11):1169-74. PubMed ID: 10564066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]